Therapeutic innovation in the dermatology space is continuing to grow at an ever-increasing rate and this has propelled a rising development in the awareness of the pathophysiology of skin conditions. In turn, there is an increasing availability of various treatment options for chronic, moderate to severe dermatological diseases and high unmet need, which globally concerns the lives of millions of individuals. As opportunity in this landscape increases, organisations and experts are motivated to draw their attention on producing further innovative efficient therapies to market.
Following a successful launch in Europe in 2019, the 2nd Dermatology Drug Development Europe Summit, returns to 2021 in a fully digital format. As we weren’t able to meet in 2020, the need to meet next year has increased. The only end-to-end industry meeting committed to collaboratively generating new dermatological therapeutics to market. This year’s summit delivers an unrivalled prospect to industry experts in the dermatology space to examine methods to tackle key challenges and review opportunities in developing and bringing to market pioneering dermatology medicines.
Join peers and leaders in this space for an exclusive three-day virtual meeting of comprehensive discussion, sharing of latest advances and pioneering insights, and networking opportunities.
